我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

两种血管升压药物治疗婴幼儿复杂心脏手术后血管舒张性休克的疗效比较

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2013年第6期
页码:
692-694
栏目:
临床研究
出版日期:
2013-11-25

文章信息/Info

Title:
Application of vasopressin and norepinephrine in treatment of infants with vasodilator shock after complicated cardiac surgerg
作者:
祁 明1郑 萍11黄维勤2袁 婷2袁 辉2
(武汉亚洲心脏病医院:1.ICU,2.麻醉科,湖北 武汉 430022)
Author(s):
QI Ming1 ZHENG Ping1 HUANG Wei qin2 YUAN Ting2 YUAN Hui2
(1.Cardiovascular Surgery ICU, 2.Department of Anesthesiology, Wuhan Asia Heart Hospital, Wuhan 430022, Hubei, China
关键词:
血管加压素心脏外科手术血管舒张性休克血流动力学
Keywords:
vasopressin cardiac surgery vasodilator shock hemodynamics
分类号:
R541.1;R972
DOI:
-
文献标识码:
A
摘要:
目的:比较血管加压素(AVP)和去甲肾上腺素(NE)对婴幼儿复杂先天性心脏病手术后血管舒张性休克患者的疗效。方法:回顾性总结2010年6月~2012年10月32例心脏术后早期使用小剂量AVP的复杂婴幼儿心脏手术患者(试药组),与2008年8月~2010年5月实施的另外35例早期使用去甲肾上腺素(NE)的复杂婴幼儿心脏手术患者(对照组)的临床资料进行比较。结果:两组患者基本资料、心率、血压、中心静脉压、最高乳酸值、最低中心静脉血氧饱和度(ScvO2)、静动脉二氧化碳分压差(Pcv-aCO2) 、尿量、胸引量组间差异不显著 ;AVP组血管活性药物评分更低、心率失常发生率更低、呼吸机辅助时间及住监护室时间减少。结论:AVP改善体外循环下术后血管舒张性休克患者的疗效优于NE。
Abstract:
AIM:To evaluate the hemodynamic effects of vasopressin in patients with vasodilator shock after cardiac operation. METHODS: A retrospective review was conducted and compared in 32 cases of infants who underwent complex cardiac operation from June 2010 to October 2012 and were treated with early use of small doses of AVP postoperatively and 35 cases of infants who underwent the same operation from August 2008 to May 2010 but were treated with early use of norepinephrine postoperatively. RESULTS: No significant difference was found between groups in basic data, heart rate, blood pressure, central venous pressure, maximum lactate value, minimum of ScvO2, Pcv-aCO2, urine volume and chest drainage. However, in AVP group, the vasoactive drug score and rate of arrhythmia were lower, and the time of mechanical ventilation and length of stay in ICU was reduced. CONCLUSION: AVP improves postoperative hemodynamics in patients suffering from vasodilator shock after cardiopulmonary bypass.

参考文献/References

[1]Sesaki M,Komeichi T,Suzuki S,et al.Evaluation of cerebral pefusion in a patient with chronic occlusive cerebrovascular disease using MRI perfusionweighted imaging(PI)[J].No Shinkei Geka,1999,27(12):1121-1126.
[2]Landry DW,Oliver JA.The pathogeneais of vasodilatory shock[J].N EngI J Med,2001,345(8):588-595.
[3]丁文祥,苏肇伉.小儿心脏重症监护手册[M].上海: 世界图书出版公司,2009:41-42.
[4]Papadpoulos G,Sintou E,Siminelakis S,et al.Perioperative infusion of lowdose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass graftingA doubleblind randomized study[J].J Cardiothorac Sury,2010,5:7.
[5]Fischer GW,Levdin MA.Vasoplegia during cardiac surgery:current concepts and management[J].Semin Thorac Cardiovasc Surg,2010,22(2):140-144.
[6]Argenziano M,Chen JM,Choudhri AF,et al.Managerment of vasodilatory shock after cardiac surgery:identification of predisposing factors and use of a novel pressor agent[J].J Thorac Cardiovasc Sury,1998,116(6):973-980.
[7]Novella S,Martinez AC,Pagan RM,et al.Plasma levels end vascular effects of vasopressin in patients undergoing coronary artery bypass grafting[J].Eur J Catdiothorac Surg,2007,32(1):69-76.
[8]Yang G,Liu L,Xu J,et al.Effect of arginine vasopressin on vascular reactivity and calcium sensitivity after hemorrhagic shock in rats and its relationship to Rhokinase[J].J Trauma,2006,61(6):1336-1342.
[9]Gessner P.The effects of vasopressin on the renal system in vasodilatory shock[J].Dimens Crit Care Nurs,2006,25(1):1-8.

备注/Memo

备注/Memo:
收稿日期:2013-03-17.通讯作者:袁辉,主治医师,主要从事重症医学研究 Email:yuanhui197952@163.com 作者简介:祁明,主治医师,硕士 Email:taddy1875@hotmail.com
更新日期/Last Update: 2013-11-20